Product Information

CABERGOLINE 0.5 MG TABLET is a generic product labeled by Somerset Therapeutics, LLC, priced at $1.3068 per EA under NDC 70069082408. Its NADAC has been published 91 times since Feb 26, 2025.

FDA first approved this application on Sep 9, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CABERGOLINE 0.5 MG TABLET

CABERGOLINE
$1.3068per EA

Strength

.5 mg/1

NDC

70069082408

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CABERGOLINE

Approval Type

Generic (ANDA)

FDA Application

ANDA218109

FDA Approved

9/9/2024

TE Code

AB

On Market Since

10/18/2024

Pharmacological Classes

Price Statistics

The NADAC for CABERGOLINE 0.5 MG TABLET has been published 91 times since Feb 26, 2025, and over the history we have for it it has declined 11.7%. The table below summarizes its recorded NADAC range and movement.

Current price$1.3068 per EA
All-time high$1.6393 (Jun 11, 2025)
All-time low$1.2892 (Oct 21, 2026)
52-week high$1.4724
52-week low$1.2892
Median price$1.4462
Average price$1.4591
Largest weekly change+9.1% (Mar 19, 2025)
Weeks tracked91
Tracking sinceFeb 26, 2025

Price History

1W

+1.4%

1M

+0.9%

3M

-2.9%

6M

-11.2%

1Y

-8.5%

3Y

N/A

5Y

N/A

All

-11.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CABERGOLINE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CABERGOLINE 0.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CABERGOLINE 0.5 MG TABLET, manufactured by Somerset Therapeutics, LLC, is $1.3068 per EA (NDC 70069082408), effective Nov 18, 2026.

How has the price of CABERGOLINE 0.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for CABERGOLINE 0.5 MG TABLET has declined 11.7%. It has been tracked across 91 weekly CMS publications since Feb 26, 2025.

What are the highest and lowest recorded NADAC prices for CABERGOLINE 0.5 MG TABLET?

Since Feb 26, 2025, the NADAC for CABERGOLINE 0.5 MG TABLET has ranged from a low of $1.2892 (Oct 21, 2026) to a high of $1.6393 (Jun 11, 2025), with a median of $1.4462 per EA.

Are there cheaper alternatives to CABERGOLINE 0.5 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of CABERGOLINE 0.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures CABERGOLINE 0.5 MG TABLET?

CABERGOLINE 0.5 MG TABLET (NDC 70069082408) is labeled by Somerset Therapeutics, LLC, and CMS classifies it as a generic product.